Patents by Inventor Claudia Schutz

Claudia Schutz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124413
    Abstract: Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
    Type: Application
    Filed: April 13, 2023
    Publication date: April 18, 2024
    Inventors: Xinyuan WU, Bertrand L. CHENARD, Nili Claudia SCHUTZ, Dov TERKIELTAUB
  • Patent number: 11807621
    Abstract: Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
    Type: Grant
    Filed: January 28, 2021
    Date of Patent: November 7, 2023
    Assignee: KAMARI PHARMA LTD.
    Inventors: Xinyuan Wu, Bertrand L. Chenard, Nili Claudia Schutz, Dov Terkieltaub
  • Publication number: 20220332697
    Abstract: Provided herein is a compound of formula (XXXII) or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer thereof or a physiologically functional derivative thereof, wherein R1, R2, R3, G, A, E, n, p, and q are defined herein. Also provided herein are compositions comprising a compound of formula (XXXII), and methods of using a compound of formula (XXXII), e.g., in the treatment or prevention of skin disorders.
    Type: Application
    Filed: January 28, 2021
    Publication date: October 20, 2022
    Inventors: Xinyuan WU, Bertrand L. CHENARD, Nili Claudia SCHUTZ, Dov TERKIELTAUB
  • Patent number: 5169873
    Abstract: Process for the manufacture of foams with the aid of blowing agents containing fluoroalkanes and fluorinated ethers, and foams obtained by this process. The invention relates to a process for the manufacture of foams based on polyisocyanates by the reaction of polyisocyanates, compounds containing at least two hydrogen atoms reactive towards isocyanate groups, blowing agents and, if appropriate, other additives. The blowing agents used consist to the extent of at least 10 mol % of at least one fluoroalkane of formula (I), C.sub.a H.sub.b F.sub.c, where a=2-6, b=1-12, and c=2-13, and at least one fluorinated ether of formula (II), C.sub.a H.sub.b F.sub.c O-C.sub.d H.sub.e F.sub.f, where a=1-6, b=1-12, c=1-12, d=1-2, e=0-5 and f=0-5. The invention further relates to the foams obtained by this process.
    Type: Grant
    Filed: March 4, 1991
    Date of Patent: December 8, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Klaus-Jurgen Behme, Hans-Matthias Deger, Claudia Schutz
  • Patent number: 5155141
    Abstract: The invention relates to a process for the production of foams based on polyisocyanates by reaction of polyisocyanates, compounds having at least two hydrogen atoms which are reactive toward isocyanate groups, blowing agents and if appropriate other additives. A blowing agent which consists to the extent of at least 10 mol % of one or more branched dodecafluorohexanes is used here.
    Type: Grant
    Filed: March 26, 1992
    Date of Patent: October 13, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Hans-Matthias Deger, Klaus J. Behme, Claudia Schutz